This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2010 Apr;35(4):936-8; author reply 938-40.

doi: 10.1183/09031936.00132009.

Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective

Z F Udwadia, T Sen, G Moharil

PMID: 20356997
DOI: 10.1183/09031936.00132009

Free article

Clinical Trial

Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective

Z F Udwadia et al. Eur Respir J. 2010 Apr.

Free article

. 2010 Apr;35(4):936-8; author reply 938-40.

doi: 10.1183/09031936.00132009.

Authors

Z F Udwadia, T Sen, G Moharil

PMID: 20356997
DOI: 10.1183/09031936.00132009

No abstract available

PubMed Disclaimer

Comment on

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.
Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C; TBNET Study Group. Migliori GB, et al. Eur Respir J. 2009 Aug;34(2):387-93. doi: 10.1183/09031936.00009509. Epub 2009 Mar 12. Eur Respir J. 2009. PMID: 19282348

Similar articles

Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
Singla R, Caminero JA, Jaiswal A, Singla N, Gupta S, Bali RK, Behera D. Singla R, et al. Eur Respir J. 2012 Apr;39(4):956-62. doi: 10.1183/09031936.00076811. Epub 2011 Sep 29. Eur Respir J. 2012. PMID: 21965225 Clinical Trial.
Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
Schaaf HS, Willemse M, Donald PR. Schaaf HS, et al. Pediatr Infect Dis J. 2009 Aug;28(8):748-50. doi: 10.1097/INF.0b013e31819bc491. Pediatr Infect Dis J. 2009. PMID: 19633523
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
Abbate E, Vescovo M, Natiello M, Cufré M, García A, Gonzalez Montaner P, Ambroggi M, Ritacco V, van Soolingen D. Abbate E, et al. J Antimicrob Chemother. 2012 Feb;67(2):473-7. doi: 10.1093/jac/dkr500. Epub 2011 Dec 1. J Antimicrob Chemother. 2012. PMID: 22134348
[The analysis of clinical data about the treatment of linezolid against tuberculosis].
Nie WJ, Chu NH. Nie WJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):601-3. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24252739 Review. Chinese. No abstract available.
[Linezolid].
Yanagihara K, Yanagihara K, Kohno S. Yanagihara K, et al. Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:352-9. Nihon Rinsho. 2007. PMID: 17455645 Review. Japanese. No abstract available.

See all similar articles

Cited by

Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.
Agyeman AA, Ofori-Asenso R. Agyeman AA, et al. Ann Clin Microbiol Antimicrob. 2016 Jun 22;15(1):41. doi: 10.1186/s12941-016-0156-y. Ann Clin Microbiol Antimicrob. 2016. PMID: 27334498 Free PMC article.
Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.
Zhang X, Falagas ME, Vardakas KZ, Wang R, Qin R, Wang J, Liu Y. Zhang X, et al. J Thorac Dis. 2015 Apr;7(4):603-15. doi: 10.3978/j.issn.2072-1439.2015.03.10. J Thorac Dis. 2015. PMID: 25973226 Free PMC article.
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D; Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017. Lan Z, et al. Lancet Respir Med. 2020 Apr;8(4):383-394. doi: 10.1016/S2213-2600(20)30047-3. Epub 2020 Mar 17. Lancet Respir Med. 2020. PMID: 32192585 Free PMC article.
Linezolid for drug-resistant pulmonary tuberculosis.
Singh B, Cocker D, Ryan H, Sloan DJ. Singh B, et al. Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2. Cochrane Database Syst Rev. 2019. PMID: 30893466 Free PMC article.
Assessment of linezolid efficacy, safety and tolerability in the treatment of tuberculosis: A retrospective case review.
Tse-Chang A, Kunimoto D, Der E, Ahmed R. Tse-Chang A, et al. Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e50-2. doi: 10.1155/2013/535616. Can J Infect Dis Med Microbiol. 2013. PMID: 24421829 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Medical
- MedlinePlus Health Information